Page 5 - Michaela Zasloff News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Michaela zasloff. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Michaela Zasloff Today - Breaking & Trending Today

Amphastar Pharmaceuticals (NASDAQ:AMPH) Price Target Increased to $71.00 by Analysts at Piper Sandler

Amphastar Pharmaceuticals (NASDAQ:AMPH – Free Report) had its price objective upped by Piper Sandler from $66.00 to $71.00 in a research report released on Wednesday morning, FlyOnTheWall reports. Several other equities research analysts have also weighed in on AMPH. Jefferies Financial Group started coverage on Amphastar Pharmaceuticals in a research note on Tuesday, July 25th. […] ....

United States , Michaela Zasloff , Richardk Prins , Piper Sandler , Institutional Trading Of Amphastar Pharmaceuticals , Amphastar Pharmaceuticals Company Profile , Amphastar Pharmaceuticals , Insider Transactions At Amphastar Pharmaceuticals , Anfield Capital Management , Jefferies Financial Group , Amphastar Pharmaceuticals Price Performance , Amphastar Pharmaceuticals Inc , News Ratings For Amphastar Pharmaceuticals Daily , Envestnet Asset Management Inc , Raymond James Associates , Free Report , Financial Group , Get Free Report , Director Michael , Director Richard , Montreal Can , Asset Management , Capital Management , State Retirement System , Raymond James , Finished Pharmaceutical Products ,

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Director Sells $316,350.00 in Stock

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) Director Michael A. Zasloff sold 7,500 shares of Amphastar Pharmaceuticals stock in a transaction dated Monday, May 15th. The shares were sold at an average price of $42.18, for a total transaction of $316,350.00. Following the completion of the transaction, the director now directly owns 43,869 shares of […] ....

Michaela Zasloff , Blackrock Inc , Hermes Inc , Dimensional Fund Advisors , News Ratings For Amphastar Pharmaceuticals Daily , Amphastar Pharmaceuticals Company Profile , Amphastar Pharmaceuticals Trading , Amphastar Pharmaceuticals Inc , Vanguard Group Inc , Quarter For Amphastar Pharmaceuticals , Amphastar Pharmaceuticals , Get Rating , Director Michael , Fund Advisors , State Street Corp , Street Corp , Finished Pharmaceutical Products , Active Pharmaceutical Ingredients Products , Amphastar Pharmaceuticals Daily , Nasdaq Amph , Insider Trading , Nsider Trades ,

Michael A. Zasloff Sells 7,500 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Stock

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) Director Michael A. Zasloff sold 7,500 shares of the firm’s stock in a transaction on Monday, May 15th. The stock was sold at an average price of $42.18, for a total value of $316,350.00. Following the transaction, the director now owns 43,869 shares in the company, valued at […] ....

United States , Michaela Zasloff , Amphastar Pharmaceuticals Company Profile , Mutual Of America Capital Management , Institutional Trading Of Amphastar Pharmaceuticals , Great West Life Assurance Co , Amphastar Pharmaceuticals , Amphastar Pharmaceuticals Stock Performance , Prudential Financial Inc , Quarter For Amphastar Pharmaceuticals , News Ratings For Amphastar Pharmaceuticals Daily , Board Of Administration Florida Retirement System , Securities Exchange Commission , Amphastar Pharmaceuticals Inc , Renaissance Technologies , Get Rating , Director Michael , Exchange Commission , Florida Retirement System , West Life Assurance , America Capital Management , Prudential Financial , Finished Pharmaceutical Products , Active Pharmaceutical Ingredients Products , Amphastar Pharmaceuticals Daily , Nasdaq Amph ,

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Expected to Post Earnings of $0.37 Per Share

Brokerages expect Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) to post earnings of $0.37 per share for the current quarter, Zacks reports. Two analysts have provided estimates for Amphastar Pharmaceuticals’ earnings. The highest EPS estimate is $0.40 and the lowest is $0.33. Amphastar Pharmaceuticals reported earnings per share of $0.21 in the same quarter last […] ....

United States , Jacky Zhang , Michaela Zasloff , Piper Sandler , Securities Exchange Commission , Zacks Investment Research , Amphastar Pharmaceuticals Inc , Lazard Asset Management , Amphastar Pharmaceuticals , Advisor Group Holdings Inc , Wells Fargo Company , Amphastar Pharmaceuticals Get Rating , Royal Bank , Get Rating , Amphastar Pharmaceutical , Investment Research , Wells Fargo , Director Michael , Exchange Commission , Asset Management , Group Holdings , Finished Pharmaceutical Products , Nasdaq Amph ,

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Receives Consensus Rating of "Buy" from Brokerages

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) has been assigned an average rating of “Buy” from the six ratings firms that are presently covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 1-year price objective among brokers […] ....

United States , Michaela Zasloff , Piper Sandler , Williamj Peters , Securities Exchange Commission , Zacks Investment Research , Amphastar Pharmaceuticals Inc , Lazard Asset Management , Amphastar Pharmaceuticals , Advisor Group Holdings Inc , Wells Fargo Company , Amphastar Pharmaceuticals Get Rating , Royal Bank , Get Rating , Exchange Commission , Director Michael , Asset Management , Group Holdings , Finished Pharmaceutical Products , Nasdaq Amph ,